HIGHLIGHTS
- who: Report and colleagues from the Department of Internal Medicine, Security Forces Hospital Program, Riyadh, SAU Oncology, King Faisal Specialist have published the article: Review began 05/13/2022 Review ended 05/15/2022 Published 05/23/2022 u00a9 Copyright, in the Journal: (JOURNAL) of May/23,/2022
- what: In the present case report, the authors report the clinical activity of pazopanib in a Pseudomyogenic hemangioendothelioma patient.
- future: Studies with more patients are required to clarify the role of pazopanib in PHE.
SUMMARY
Soft tissue sarcoma (STS) is a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.